Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;64(8):e170-e176.
doi: 10.1111/epi.17634. Epub 2023 Jun 8.

IRF2BPL as a novel causative gene for progressive myoclonus epilepsy

Affiliations

IRF2BPL as a novel causative gene for progressive myoclonus epilepsy

Elena Gardella et al. Epilepsia. 2023 Aug.

Abstract

IRF2BPL has recently been described as a novel cause of neurodevelopmental disorders with multisystemic regression, epilepsy, cerebellar symptoms, dysphagia, dystonia, and pyramidal signs. We describe a novel IRF2BPL phenotype consistent with progressive myoclonus epilepsy (PME) in three novel subjects and review the features of the 31 subjects with IRF2BPL-related disorders previously reported. Our three probands, aged 28-40 years, harbored de novo nonsense variants in IRF2BPL (c.370C > T, p.[Gln124*] and c.364C > T; p.[Gln122*], respectively). From late childhood/adolescence, they presented with severe myoclonus epilepsy, stimulus-sensitive myoclonus, and progressive cognitive, speech, and cerebellar impairment, consistent with a typical PME syndrome. The skin biopsy revealed massive intracellular glycogen inclusions in one proband, suggesting a similar pathogenic pathway to other storage disorders. Whereas the two older probands were severely affected, the younger proband had a milder PME phenotype, partially overlapping with some of the previously reported IRF2BPL cases, suggesting that some of them might be unrecognized PME. Interestingly, all three patients harbored protein-truncating variants clustered in a proximal, highly conserved gene region around the "coiled-coil" domain. Our data show that PME can be an additional phenotype within the spectrum of IRF2BPL-related disorders and suggest IRF2BPL as a novel causative gene for PME.

Keywords: IRF2BPL; ataxia; cerebellar signs; neurodevelopmental disorder; progressive myoclonus epilepsy.

PubMed Disclaimer

References

REFERENCES

    1. Michelucci R, Serratosa JM, Delgado-Escueta AV, Genton P, Riguzzi P, Tassinari CA. Progressive myoclonic epilepsies. In: Bureau M, Genton P, Dravet C, Delgado-Escueta AV, Guerrini R, Tassinari CA, et al., editors. Epileptic syndromes in infancy, childhood and adolescence. 6th ed. Montrouge, Ile-de-France: John Libbey Eurotext; 2019. p. 571-610.
    1. Canafoglia L, Franceschetti S, Gambardella A, Striano P, Giallonardo AT, Tinuper P, et al. Progressive myoclonus epilepsies. Diagnostic yield with next-generation sequencing in previously unsolved cases. Neurol Genet. 2021;7:e641.
    1. Marcogliese PC, Shashi V, Spillmann RC, Stong N, Rosenfeld JA, Koenig MK, et al. IRF2BPL is associated with neurological phenotypes. Am J Hum Genet. 2018;103:245-60.
    1. Tran Mau-Them F, Guibaud L, Duplomb L, Keren B, Lindstrom K, Marey I, et al. De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy. Genet Med. 2019;21:1008-14.
    1. Ganos C, Biskup S, Krüger S, Meyer-Osores A, Hodecker S, Hagel C, et al. Dystonia with aphonia, slow horizontal saccades, epilepsy and photic myoclonus: a novel syndrome? Parkinsonism Relat Disord. 2014;20:328-31.